96 results
Page 3 of 5
10-K
EX-10.6
5os85
24 Mar 22
Annual report
7:30am
10-K
kv01liv
24 Mar 22
Annual report
7:30am
8-K
EX-99.1
gq8i0ew1919
15 Mar 22
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results
7:31am
8-K
EX-99.1
mih13v83uf
31 Jan 22
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
9:00am
6-K
EX-99.1
dejhk
15 Nov 21
Gamida Cell Reports Third Quarter 2021 Financial Results
7:29am
6-K
EX-99.1
bepag23ft52e690
26 Oct 21
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
7:30am
6-K
EX-99.1
tmnq99s1yw o6y
12 Oct 21
Report of Foreign Private Issuer
4:32pm
F-3
EX-1.2
tmyq5k9
13 Sep 21
Shelf registration (foreign)
12:00am
6-K
EX-99.1
fzke245mnv40gf7vadc
13 Aug 21
Report of Foreign Private Issuer
4:04pm
6-K
EX-99.1
sts7cx6zbi
11 May 21
Gamida Cell Reports First Quarter 2021 Financial Results and Provides Company Update
8:28am
6-K
EX-99.1
ylzmsq zjjlju5b
9 Mar 21
Gamida Cell Reports Full Year 2020 Financial Results and Provides Company Update
4:08pm
6-K
EX-99.1
iopgt6
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-4.1
hey5uao6gmr
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-99.1
349x g7ufpdhsv
14 Dec 20
Gamida Cell Provides Regulatory Update
4:14pm
6-K
EX-99.1
rjbz81a
9 Dec 20
Report of Foreign Private Issuer
3:37pm
6-K
EX-99.1
zh73ff0d
8 Dec 20
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
3:19pm
6-K
EX-99.1
kvpn i3u4
10 Nov 20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
8:23am
6-K
EX-99.1
p04jvbnagkrg2xea n5
5 Nov 20
Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
10:36am